Neuropsychopharmacological Effects of Dacryodes edulis Pulp Oil in Unpredictable Chronic Mild Stress Model of Depression in Mice
Landry Martial Miguel1*, Nadège Okemy-Andissa2, Didier Gesril N’Jilo1, Etienne Mokondjimobe1,2, Donatien Moukassa1,3 and Ange Antoine Abena1
1Faculty of Health Sciences, Marien NGOUABI University, BP 69 Brazzaville (Congo)
2National Public Health Laboratory, Brazzaville (Congo)
3Edith Lucie Bongo Ondimba General Hospital, Oyo, Brazzaville (Congo)
Submission: September 01, 2019; Published: September 16, 2019
*Corresponding author: Landry Martial Miguel, Faculty of Health Sciences, Marien NGOUABI University, BP 69 Brazzaville (Congo)
How to cite this article: Landry Martial Miguel, Nadège Okemy-Andissa, Didier Gesril N’Jilo, Etienne Mokondjimobe, Donatien Moukassa, Ange Antoine Abena. Neuropsychopharmacological Effects of Dacryodes edulis Pulp Oil in Unpredictable Chronic Mild Stress Model of Depression in Mice. Psychol Behav Sci Int J. 2019; 13(3): 555861. DOI: 10.19080/PBSIJ.2019.13.555861.
Abstract
Goal: To investigate the effects of prolonged (30-day) fruit oil administration of Dacryodes edulis (G. Don) HJ Lam (HDE) on the symptoms of depression induced by unpredictable chronic middle stress in mice.
Methods: Depression was induced by daily exposure animals to a succession of stressors for 6 weeks. Coat state, latency and the duration of immobility in the forced swimming and tail suspension tests were then determined after treatment with HDE (5 and 10ml/kg) and fluoxetine (2,5 mg/kg) for 4 weeks.
Results: HDE, at doses of 5 and 10ml/kg, improves the score related to coat state, increases latency and decreases the duration of animal immobility in forced swimming and caudal suspension tests. These results are similar to those obtained with fluoxetine (FLU).
Conclusion: The results confirm the antidepressant effects of HDE on symptoms of depression, in an unpredictable chronic middle stress model, after prolonged administration in mice.
Keywords: Dacryodes edulis; Depression; Neuropsychopharmacological; UCMS
Introduction
Stress is a crucial determinant for maintenance of health and disease [1,2]. There are various neuropsychiatric problems such as anxiety, cognitive dysfunction, depression etc., are generally associated with stress [3]. Depression is a mental condition that is characterized by affective, physical, physiological and cognitive deterioration [4-6]. It affects about 20% of the world’s population [7]. To date, drug therapies available include tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) or noradrenalin (ISRN), and several other antidepressants such as monoamine oxidase inhibitors – MAOIs [8]. However some of these drugs have many side effects such as fatigue, sedation, apathy, sleep disorders, making it necessary, the development of other drugs more effective and better tolerated. In the clinic, several scales are used to assess the intensity of stress or depression; Hamilton Depression Rating Scale (HDRS), Montgomery-Asberg Depression Rating Scale (MADRS) or Beck Depression Inventory (BDI). These tests are based on behaviors assessment related to the symptoms of depression. Stress has an important role in the development of human depression [9]. The socio-environmental chronic stressors influencing the development of depression and stress in animal models, have been used to explore the biochemical mechanisms of these disorders. These models reproduce the symptomatology of depression observed in men [7,10]. It has been established that prolonged exposure of an animal to a variety of stressors is associated with significant behavioral, physiological, endocrine and neurobiological changes. These changes are corrected by chronic antidepressant treatments [11,12].
Reactive oxygen species (ROS) may play a role in some neuropsychiatric disorders such as major depression. There is some evidence that the activation of immune-inflammatory process, increased monoamine catabolism, and abnormalities in lipids may cause overproduction of ROS, lipid peroxidation, and reduced antioxidant enzyme activities, and these processes may be related to pathophysiology of depression [13].
Dacryodes edulis (G. Don) HJ. Lam (Burseraceae), is a potent natural antioxidant and is currently receiving considerable attention in relation to neuropsychological disorders. Phytochemical studies have revealed the presence of various chemical compounds that would justify the medicinal indications of this plant. The fruits of D. edulis are rich in lipids, proteins, vitamins and antioxidants. Pharmacological studies have shown psychotropic properties of antidepressant and anxiolytic types [14,15].
In present study, we have evaluated the antidepressant-like effect of long term administration of Dacryodes edulis fruit oil in UCMS paradigm by investigating chronic stress induced behavioral alterations in mice.
Material and Methods
Preparation of the essential oil
The fruits were pitted, and the pulp put to dry room temperature until needed. Fractions of 500g dried pulp fruit were submitted to hydro distillation for approximately 3h. Oil extracting was dried by placing at 37°C until needed. The concentrated oil sample was used for experiments, in the dilution of 10% in distillated water.
Animals
Adult male mice aged between 6 to 8 weeks, from the animal house of the Faculty of Health Sciences of the Marien Ngouabi University (Brazzaville), were used. They were raised in polypropylene cages, at an ambient temperature of 25°C and a light/dark cycle of 12h/12, with free access to water and food. All experiments were conducted in compliance with Directive 2010/6106/EU, on the protection of laboratory animals [16]. Animals were divided into 4 lots of 5 mice; distilled water (5ml/kg), fluoxetine (FLU) 2,5mg /kg, D. edulis (HDE) oil, 5 and 10ml/kg. Positive control and treated groups were subjected to an unpredictable moderate chronic stress (UCMS) protocol, for 6 weeks [17,18]. The different products were administered daily orally, at the same time and 2 weeks after the start of the protocol, until the end of it (Figure 1).
Unpredictable chronic mild stress protocol
Unpredictable chronic mild stress protocol was previously described by Surget [19] and several variants have been proposed [12]. In our protocol, mice were routinely subjected to a variety of socio-environmental stressors, following a pre-established schedule, for a duration of 6 weeks (Table 1). The different stressors were: alteration of the soiled sawdust, clean, wet, change of cage, substitution of the sawdust by water, cage tilt at 45°, inversion of the light/dark cycle, bath.
The different products were administered orally daily, during 4 weeks, 14 days following the start of the protocol. 24 hours after the cessation of the stress protocol, all the animals were subjected to the open field test, forced swimming test (J + 2 post protocol) and tail suspension test (J + 3 post protocol).
Body weight and coat state
Body weight and coat state were assessed weekly as predictors of unpredictable chronic moderate stress and protocol validity, consistent with the protocol reported by Laugeray et al. [18]. The evaluation of the coast state was carried out by assessment of 8 different body parts: head, neck, dorsal coat, ventral coat, tail, forepaws, hind paws and genital region [20]. A score of 0 was attributed to a smooth coat, in good state. Dirty state was characterized by a flu fly, greasy, less dense coat or piloerection, and attributed to a score of 1 for a coat. Sum of score obtained with each of these different parts gave us an index of general physical state of an animal.
Forced swimming test
The principle of forced swimming test (FST) lies in its supposed relationship with resignation behavior. It is a behavioral test mainly used to predict the effectiveness of antidepressant treatment [20,21]. It involves subjecting the animals to forced swimming for 6 minutes. After vigorous activity for two minutes, the animal stops swimming and freezes, adopting a behavior of resignation that can be associated with “despair”. It is considered that the mouse is immobile when it floats in a horizontal position and makes only movements of small amplitude allowing him to keep his head out of the water.
The mice were placed in a cylinder (19cm diameter, 23cm deep), filled to two-thirds with 23-25°C water and the latency (time that the animal puts before the immobilization) of the first immobilization as well as the total duration of immobility or floating are recorded. Only the last 4 min were scored for mobility duration. Immediately after the test, the mouse is placed in a heating chamber for 10 minutes to promote its recovery.
Caudal suspension test
The tail suspension test (TST) is used to evaluate the antidepressant properties of a substance. It is based on the fact that an animal suspended by the tail presents alternating periods of agitation and immobility. The duration of immobility is considered as an index of resignation. Mice were suspended in the air using a paper clip fixed by tape wrapped around their tails about 20mm from the extremity of the tail. The duration of immobility was recorded during the last 4min of the 6min test [6,22,23]. Antidepressants reduce the total duration of this immobility.
Statistical analysis
The results were analyzed with the InStat 3.036 software and averaged ± standard error. We used the test t of Student with a significance level set at p <0.05.
Results
Figures 2 and 3 show respectively the weight change and the state of the coat of animals subjected to chronic stress. The stress model used significantly inhibits weight gain from the six weeks of the protocol (Figure 2). We also observed a deterioration in the coat state which is observed at the first week of the protocol to the sixth (Figures 3 & 4), resulting in a significant increase in the score attributed to the state of the coat: p <0.001. Figure 4 illustrates the coat state of the animal submitted (a) or not (b) to the UCMS protocol.
Effects of HDE on the coat state of animals
Figure 5 shows the effects of the treatments on the animal coat state. The results show that the degradation of the coat state is corrected from the 4th week of treatment. This correction is significant (p <0.001) at the 5th and 6th week.
Forced swimming test (FST)
D. edulis and fluoxetine increase the latency of animals and significantly reduce (p<0.01) the duration of immobility in the forced swimming test (Figures 6 & 7).
Caudal suspension test
D. edulis and fluoxetine increase the latency of animals in the tail suspension test and significantly reduce (p <0.01) the duration of immobility (Figures 8 & 9).
Discussion
Many studies report that a complex relationship is there among stressful situations, mind and body’s reaction to stress, and the onset of clinical depression [3]. Some stress-provoked disorders seem to be associated with the pathophysiology of depression [24]. Depression and stress are associated with functional and morphological changes in the nervous system [25]. The chronic administration of various uncontrollable stressors in an unpredictable manner is a well-documented animal model for the preclinical evaluation of antidepressants [26,27,28]. Unpredictable Chronic Mild Stress (UCMS) induces a complex syndrome, similar to the symptoms of major depression observed in human pathology. As a result, this model has a very good descriptive validity [3].
In this study, we used the unpredictable mild chronic stress model to evaluate the effects of long-term administration of D. edulis oil on stress-induced symptoms of depression. The mice were exposed to a series of physical and psychosocial stress. The behavioral parameters analyzed in our experiments were the coat state, latency and the duration of immobility in the FST and the TST.
In mice, grooming is a behavior that is very sensitive to stress [29,30]. In UCMS model, the deterioration of the coat state observed is related to the decrease in the grooming behavior, consequence of the neurobiological changes caused by the prolonged exposure to the different stressors [31]. In clinic, the equivalent of this symptomatology is the lack of hygiene observed to some depressant patients. The results obtained showed a significant degradation of the state of the fur of the animals subjected to the UCMS. In fact, the deterioration of the coat as a result of chronic stress has been observed in many studies [18,32]. In the present study, degradation of the state coat, bio-behavioral marker, settles in the first week of stress and continues throughout the duration of the protocol. Degradation of the coat state, associated with loss of body weight gain, is a characteristic that reflects depression [31], and validates the stress protocol. This observation is consistent with the literature data [19,31,33]. The importance of losing weight gain depends on the duration, timing and type of stressors used [31]. In our study, the loss of weight gain with UCMS group was significant from the 5th week of the stress protocol.
Increased animal immobility in the FST and TST is considered a marker of anxiety behavior [21,34]. Mice that were exposed to a regime of chronic stress exhibited greater immobility period as compared to control animals. The increase in immobility time was significantly reversed by daily administration of HDE. UCMS has been shown to cause decreased immobility in the FST and TST in animals. These observations corroborate with the interpretation of this behavior conventionally carried out in this paradigm [6,35]. Our results indicate that HDE increases latency and decreases immobility in the FST and TST. In these tests, it is estimated that the latency of animals before immobility is linked to an attitude of resignation / loss of motivation to get out of a dead-end situation, which we often see appearing in the literature under the term “Behavioral despair”. It has been shown that various antidepressants decrease the duration of immobility in mice [21], interpreted as an increase in motivation / combativeness in a situation that cannot be extracted. These arguments justify that chronic stress, supposed to induce a depressive state, causes an increase in the duration of immobility. However, other experimental studies have reported a decrease in immobility in the FST after chronic stress [36-38]. This diversity of observations could be attributed to methodological divergences such as water temperature or light intensity [39-41].
Despite these differences in behavioral interpretation, the relevance of this model has been reported in several studies. Indeed, it is the best model to study the pathophysiology of depressive disorders because it uses one of the main etiological factors of depression: chronic exposure to stressors, giving it a good build validity. Previous studies have shown that HDE opposes symptoms of depression and anxiety in behavioral tests after acute administration in rodent [14,15]. In this study, chronic administration of HDE restored stress-induced behavioral changes in UCMS protocol, probably by preventing oxidative stress and inflammation in mice hippocampal neurons and consequently may be improving synaptic plasticity. Subsequent studies would elucidate the neurobiological mechanisms of HDE effects in stress-induced behavioral and biochemical changes.
Conclusion
D. edulis oil administered to animals daily for 30 days, showed the antidepressant-like effect in unpredictable chronic mild stress-induced depression model in mice, by improving the symptoms of depression in the behavioral tests of forced swimming and tail suspension test. Subsequent studies would elucidate the neurobiological mechanisms of these effects of HDE.
Acknowledgmentn
The authors would like to express their gratitude to the Biochemistry and Pharmacology Laboratory, and its head, Professor Ange Antoine ABENA, for the provided experimental material.
Conflict of Interest
Authors declare there is no conflict of interest.
References
- American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, (5th edn.), American Psychiatric Publishing: Arlington, VA, USA.
- Center for Disease Control and Prevention (2014) Prevalence of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2010. Morbidity and Mortality Weekly Report. Surveillance Summaries 63: 1-21.
- Post-Traumatic Stress Disorder (PTSD) (2018) National Institutes of Mental Health, United States.
- van Steensel FJA, van Bögels SM, Perrin S (2011) Anxiety disorders in children and adolescents with autistic spectrum disorders: A metaanalysis. Clin Child Fam Psychol Rev 14(3): 302–317.
- Mehtar M, Mukaddes NM (2011) Posttraumatic Stress Disorder in individuals with diagnosis of Autistic Spectrum Disorders. Res Autism Spectr Disord 5: 539-546.
- De Bruin EI, Ferdinand RF, Meester S, de Nij PFA, Verheij F (2007) High rates of psychiatric comorbidity in PDD-NOS. J Autism Dev Disord 37(5): 877-886.
- Storch EA, Sulkowski ML, Nadeau J, Lewin AB, Arnold EB, et al. (2013) The phenomenology and clinical correlates of suicidal thoughts and behaviors in youth with autism spectrum disorders. J Autism Develop Disord 43(10): 2450-2459.
- Dell’Osso L, Dalle Luche R, Carmassi C (2015) A new perspective in post-traumatic stress disorder: Which role for unrecognized autism spectrum. International Journal of Emergency Mental Health and Human Resilience 17(2): 436-438.
- Nietlisbach G, Maercker A (2009) Social cognition and interpersonal impairments in trauma survivors with PTSD. Journal of Aggression Maltreatment & Trauma 18(4): 382-402.
- Kerns CM, Newschaffer CJ, Berkowitz SJ (2015) Traumatic childhood events and autism spectrum disorder. J Autism Dev Disord 45(11): 3475-3486.
- Stavropoulos K, Bolourian Y, Blacher J (2018) Differential Diagnosis of Autism Spectrum Disorder and Post Traumatic Stress Disorder: Two Clinical Cases. J Clin Med 7(4).
- Trelles Thorne Mdel P, Khinda N, Coffey BJ (2015) Posttraumatic stress disorder in a child with autism spectrum disorder: Challenges in management. J Child Adolesc Psychopharmacol 25(6): 514-517.
- Morries LD, Cassano P, Henderson TA (2015) Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy. Neuropsychiatr Dis Treat 11: 2159-2175.
- Hamblin MR (2016) Shining light on the head: Photo biomodulation for brain disorders. BBA Clin 6: 113-124.